Global Pharmacokinetics Services Market – Industry Trends and Forecast to 2030

Análise e dimensão do mercado de serviços farmacocinéticos

O crescimento do mercado global de serviços farmacocinéticos pode ser atribuído a vários fatores. A indústria farmacêutica tem registado uma procura consistente por novos medicamentos e terapias. Esta procura tem levado as empresas farmacêuticas a investir fortemente em investigação e desenvolvimento, levando a uma maior necessidade de estudos farmacocinéticos. Os serviços de farmacocinética auxiliam na compreensão de como os medicamentos são absorvidos, distribuídos, metabolizados e excretados pelo organismo, o que é crucial para determinar a sua eficácia e perfis de segurança. As agências reguladoras como a Food and Drug Administration (FDA) dos EUA e a Agência Europeia do Medicamento (EMA) têm requisitos rigorosos para a aprovação de novos medicamentos. Os estudos farmacocinéticos são parte integrante da demonstração da segurança e eficácia de um medicamento, garantindo que este cumpre as normas regulamentares necessárias antes de poder ser aprovado para lançamento no mercado.

A Data Bridge Market Research analisa que o mercado global de serviços farmacocinéticos, que foi de 883,46 milhões de dólares em 2022, deverá atingir os 1.554,64 milhões de dólares até 2030, e deverá passar por um CAGR de 7,30% durante o período de previsão de 2023 a 2030. “Pequeno serviços farmacocinéticos de moléculas” domina o segmento de tipo do mercado global de serviços farmacocinéticos devido ao crescente envelhecimento da população. Além dos insights sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline, análise de preços, e quadro regulamentar.

Âmbito e segmentação do mercado de serviços farmacocinéticos

Definição de mercado

A farmacocinética (PK) é uma divisão de farmacologia que se dedica a determinar o destino de medicamentos administrados a um organismo vivo. Explica como, após a administração, o organismo influencia qualquer produto químico específico através de modificações metabólicas de substâncias no organismo e da via de excreção dos metabolitos do fármaco. A farmacocinética é o estudo de como um medicamento é influenciado por um organismo. As propriedades químicas da farmacocinética são afetadas pela via de administração e pela dose de um medicamento administrado, o que pode afetar a taxa de absorção.

Dinâmica global do mercado de serviços farmacocinéticos

Motoristas

• Aumentando as atividades de desenvolvimento de medicamentos

A crescente procura de novos medicamentos e terapias levou ao aumento das atividades de desenvolvimento de medicamentos na indústria farmacêutica. Os serviços farmacocinéticos desempenham um papel crucial no desenvolvimento de medicamentos, fornecendo informações valiosas sobre a absorção, distribuição, metabolismo e eliminação de medicamentos. A necessidade de estudos farmacocinéticos para apoiar as submissões regulamentares e garantir a segurança e eficácia dos medicamentos impulsiona a procura destes serviços.

• Aumento da externalização de serviços de desenvolvimento de medicamentos

As empresas farmacêuticas estão cada vez mais a externalizar vários aspetos do desenvolvimento de medicamentos para contratar organizações de investigação (CROs) e prestadores de serviços especializados. A externalização dos serviços farmacocinéticos permite às empresas o acesso a conhecimentos especializados, instalações de última geração e tecnologias avançadas sem investimentos significativos em infraestruturas e pessoal. Esta tendência aumenta a procura de serviços farmacocinéticos a nível mundial.

• Ênfase na Medicina Personalizada

O campo da medicina personalizada está a ganhar força, com foco na adaptação de tratamentos médicos a doentes individuais com base na sua composição genética, estilo de vida e outros fatores. Os estudos farmacocinéticos ajudam a compreender a variabilidade interindividual na resposta aos medicamentos, otimizando os regimes posológicos e minimizando os efeitos adversos. O crescente interesse na medicina personalizada impulsiona a necessidade de serviços farmacocinéticos para apoiar a dosagem precisa de medicamentos.

• Requisitos regulamentares e conformidade

Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have stringent guidelines for drug development and approval. Pharmacokinetic studies are essential to demonstrate the safety, efficacy, and quality of drugs. Compliance with regulatory requirements necessitates the use of pharmacokinetics services to generate robust data and meet the necessary regulatory standards.

Opportunities

• Technological Advancements

Technological advancements in analytical techniques, such as LC-MS, high-performance liquid chromatography (HPLC), and mass spectrometry, have improved the accuracy and sensitivity of drug analysis. In addition, advances in pharmacokinetic modeling and simulation tools have enhanced the prediction and optimization of drug behavior in the body. These technological advancements have expanded the capabilities of pharmacokinetics services, making them more efficient and reliable.

• Increasing Preclinical and Clinical Research

The growth of preclinical and clinical research, including early-phase clinical trials, drives the demand for pharmacokinetics services. Pharmacokinetic studies are conducted during preclinical stages to assess drug properties and guide dose selection for human trials. In clinical trials, pharmacokinetics services help monitor drug levels in participants, evaluate drug-drug interactions, and provide insights into dosing adjustments.

Restraints/Challenges

• High Cost of Pharmacokinetic Studies

Pharmacokinetic studies can be complex and require specialized expertise, advanced equipment, and sophisticated analytical techniques. These factors contribute to the high cost of conducting pharmacokinetic studies. The cost-intensive nature of these services can limit the accessibility of pharmacokinetics services, particularly for small and medium-sized pharmaceutical companies with limited budgets.

• Stringent Regulatory Requirements

While regulatory requirements drive the demand for pharmacokinetics services, they can also pose challenges. Meeting the stringent guidelines set by regulatory agencies, such as the FDA and EMA, requires careful planning, execution, and documentation of pharmacokinetic studies. The extensive regulatory compliance process can be time-consuming and costly, potentially delaying drug development timelines and increasing overall costs.

This global pharmacokinetics services market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pharmacokinetics services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2022, Tasso, Inc., a leader in clinical-grade blood collection solutions, announced the launch of Tasso PopPK Solutions, an integrated patient-centric offering for Population Pharmacokinetics (“PopPK”). With the launch of Tasso PopPK Solutions, Tasso now enables pharmaceutical companies to operationalize pharmacokinetic studies as part of their decentralized clinical trial efforts. Tasso's remote solution supports the scalable and convenient acquisition of pharmacokinetic data, improving modeling accuracy and accelerating clinical trials
• In March 2022, Meadowhawk Biolabs, Inc., a contract research organization (CRO) formed to provide bioanalytical, pharmacokinetic and pharmacological services to biotechnology and pharmaceutical companies, is pleased to announce its launch of operations in the Boston and San Francisco areas

Global Pharmacokinetics Services Market Scope

The global pharmacokinetics services market is segmented on the basis of type, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Small Molecules Pharmacokinetics Services
• Large Molecules (Biopharmaceuticals) Pharmacokinetics Services

Application

• Small and Medium Enterprise
• Large Enterprise

Global Pharmacokinetics Services Market Regional Analysis/Insights

The global pharmacokinetics services market is analysed and market size insights and trends are provided by country, type and application as referenced above.

The countries covered in the global pharmacokinetics services market report are U.S., Canada and Mexico in North America, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global pharmacokinetics services market because of the increasing drug development activities, growing investment in healthcare infrastructure is also boosting the growth of the market.   

Asia-Pacific is expected to witness significant growth in the global pharmacokinetics services market during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed Base and New Technology Penetration

The global pharmacokinetics services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global pharmacokinetics services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global pharmacokinetics services market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Pharmacokinetics Services Market Share Analysis

The global pharmacokinetics services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global pharmacokinetics services market.

Some of the major players operating in the global pharmacokinetics services market are:

• Evotec SE (Germany)
• Certara, L.P. (U.S.)
• Pacific Biolabs Inc (U.S.)
• GVK Biosciences Private Limited (India)
• Shanghai Medicilon inc. (China)
• PPD Inc. (U.S.)
• Charles River Laboratories. (U.S.)
• Parexel International Corporation (U.S.)
• Eurofins Scientific (Luxembourg)
• Frontage Labs. (Pennsylvania)
• SGS SA (Switzerland)
• LGC Limited (U.K.)
• Creative Bioarray (U.S.)
• Biologics Consulting Group, Inc. (U.S.)
• Cyprotex Limited (U.K.)
• ICON plc (Ireland)
• Nuventra Pharma Sciences (U.S.)
• Absorption Systems (U.S.)
• Pfizer Inc. (U.S.)
• SEKISUI XenoTech, LLC (U.S.)

SKU-59145